The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The DETECT Study Program: Personalized treatment in advanced breast cancer based on circulating tumor cells (CTCs).
 
Amelie Schramm
No Relationships to Disclose
 
Thomas W. P. Friedl
Honoraria - Eisai
 
Susanne Albrecht
No Relationships to Disclose
 
Jens Bodo Huober
No Relationships to Disclose
 
Brigitte Kathrin Rack
Research Funding - Veridex
 
Elisabeth Katharina Trapp
No Relationships to Disclose
 
Peter A. Fasching
Honoraria - Amgen; Genomic Health; GlaxoSmithKline; Novartis; Pfizer; Roche Pharma AG; Teva
Consulting or Advisory Role - Novartis; Pfizer; Roche Pharma AG; Teva
Speakers' Bureau - Amgen; Genomic Health; GlaxoSmithKline; Novartis; Pfizer; Roche Pharma AG; Teva
Research Funding - Amgen; Novartis
 
Florin-Andrei Taran
No Relationships to Disclose
 
Andreas D. Hartkopf
No Relationships to Disclose
 
Andreas Schneeweiss
No Relationships to Disclose
 
Volkmar Mueller
Honoraria - Amgen; Celgene; Eisai; GlaxoSmithKline; Pierre Fabre; Roche Pharma AG; Teva
Consulting or Advisory Role - Celgene; Eisai; Pierre Fabre; Roche Pharma AG; Teva
 
Bahriye Aktas
No Relationships to Disclose
 
Klaus Pantel
No Relationships to Disclose
 
Franziska Meier-Stiegen
No Relationships to Disclose
 
Wolfgang Janni
Honoraria - Amgen; Eisai; GlaxoSmithKline; Novartis; Pierre Fabre; Roche Pharma AG; Teva
Research Funding - Amgen; Eisai; GlaxoSmithKline; Novartis; Pierre Fabre; Roche Pharma AG; Teva; Veridex
 
Tanja N. Fehm
Consulting or Advisory Role - Amgen; Novartis; Roche
Speakers' Bureau - AstraZeneca; PharmaMar; Roche
Research Funding - Novartis